Submit to our new cross-journal collection on dyslipidemia

BMC Medicine Impact Factor: 8.005 Chief Editor: Sabina Alam   BMC Medicine Impact Factor: 8.005 Chief Editor: Sabina Alam     Submit Manuscript  |  Editorial Board  |  Submission Guidelines  |  Article Alerts   Dear Dr Sfakianakis, BMC Medicine and BMC Cardiovascular Disorders will soon be launching a new cross-journal article collection focused on therapeutic advances in dyslipidemia, guest edited by Professor Maciej Banach. We encourage you to read more about the series below and to submit to your journal of choice. About the Dyslipidemia Collection Lipid disorders present one of the greatest challenges for physicians today, and a large number of ongoing randomized controlled trials are focused on lipodology. There are many questions which still need clear answers, including the effectiveness of the residual risk therapy/combination therapy with fibrates, niacin, ezetimibe (especially after recent negative FDA recommendations), as well as about new drugs for LDL-C therapy, their efficacy and safety, including PCSK9 inhibitors and ETC-1002. Continue reading Do You Have a Study to Publish? We are seeking submissions of research articles that provide important developments in dyslipidemia management. This collection will also include invited reviews and commentaries. If you have any research you would like us to consider for inclusion in our dyslipidemia cross-journal collection, please submit directly to either BMC Medicine or BMC Cardiovascular Disorders. Alternatively you can email your presubmission queries to bmcmedicineeditorial@biomedcentral.com or bmccardiovascdisord@biomedcentral.com. About BMC Medicine With an ethos of transparency and accessibility, BMC Medicine is an open access, open peer-reviewed general medical journal. As the flagship medical journal of the BMC series, the journal publishes outstanding and influential research in all areas of clinical practice, translational medicine, public health, policy, and general topics of interest to the biomedical research community. The journal's impact factor is 8.005, and we are ranked 8th out of 151 journals in the Medicine, General and Internal category in the most recent Thomson Reuters Journal Citation Report. About BMC Cardiovascular Disorders BMC Cardiovascular Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of disorders of the heart and circulatory system, as well as related molecular and cell biology, genetics, pathophysiology, epidemiology, and controlled trials. Submit now Register to receive the latest articles, straight to your inbox. Best wishes, BMC Medicine and BMC Cardiovascular Disorders Submit Manuscript Editorial Board Submission Guidelines Article Alerts Follow BioMed Central: How to ensure BioMed Central's emails reach your inbox You have received this message in a belief that it would be of interest. If you would not like to receive any further messages from BioMed Central, please visit our general unsubscribe page. For further information or enquiries please contact Customer Services at:info@biomedcentral.com. BioMed Central Ltd 236 Gray's Inn Road, London, WC1X 8HB, United Kingdom. Part of Springer Nature. Privacy Policy BMC40049   http://ift.tt/1PxqOBG

http://ift.tt/2aqZENV